Glaucoma warning
Use caution if you have glaucoma or increased eye pressure.
Leaflet EDOFLO 320mcg / 9mcg / dose inhalation powder
- Product code:
- W56419001
- Quantity:
- 1
- Indicated for:
- asthma; chronic obstructive pulmonary disease
- Route of administration:
- inhalation
- Substance:
- budesonide + formoterol (glucocorticoid + beta-2 adrenergic agonist)
- ATC
- R03AK07 — Respiratory system | Adrenergics, inhalants | Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics
Precautions:
Hyperglycemia
This medicine may increase blood sugar.
Immunosuppression / infection risk
This medicine may increase the risk of infections.
Breastfeeding warning
Use during breastfeeding only on medical advice.
Pregnancy warning
Use during pregnancy only on medical advice.
Cardiac risk / QT prolongation / arrhythmias
This medicine may increase the risk of heart rhythm disturbances.
The combination of budesonide and formoterol is used to treat asthma and chronic obstructive pulmonary disease (COPD). It combines a corticosteroid (budesonide) with a long-acting bronchodilator (formoterol), providing both inflammation control and airway relaxation.
Budesonide reduces airway inflammation, preventing asthma symptoms such as wheezing, coughing, and breathing difficulties. Formoterol acts quickly and long-term to relax airway muscles, making breathing easier and preventing asthma attacks.
This combination is used both as maintenance therapy and, in some cases, for the relief of acute symptoms. It is recommended for patients who require both long-term inflammation control and an effective bronchodilator.
Side effects may include dry mouth, throat irritation, hoarseness, tremors, or palpitations. In rare cases, severe allergic reactions, oral fungal infections (thrush), or worsening respiratory symptoms may occur. It is important for patients to rinse their mouth after using the inhaler to prevent oral infections.
Patients should strictly follow their doctor’s instructions regarding inhaler use. It is essential not to exceed the prescribed dose and to use the medication as part of the treatment plan to prevent asthma or COPD exacerbations.
Budesonide reduces airway inflammation, preventing asthma symptoms such as wheezing, coughing, and breathing difficulties. Formoterol acts quickly and long-term to relax airway muscles, making breathing easier and preventing asthma attacks.
This combination is used both as maintenance therapy and, in some cases, for the relief of acute symptoms. It is recommended for patients who require both long-term inflammation control and an effective bronchodilator.
Side effects may include dry mouth, throat irritation, hoarseness, tremors, or palpitations. In rare cases, severe allergic reactions, oral fungal infections (thrush), or worsening respiratory symptoms may occur. It is important for patients to rinse their mouth after using the inhaler to prevent oral infections.
Patients should strictly follow their doctor’s instructions regarding inhaler use. It is essential not to exceed the prescribed dose and to use the medication as part of the treatment plan to prevent asthma or COPD exacerbations.
General data about EDOFLO 320mcg / 9mcg / dose
- Substance:
- budesonide + formoterol
- Date of latest medicines list:
- 01-07-2013
- Product code:
- W56419001
- Concentration:
- 320mcg / 9mcg / dose
- Pharmaceutical form:
- inhalation powder
- Quantity:
- 1
- Product type:
- Original
- Prescription status:
- P-6L — Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.
Pharmaceutical forms available for budesonide + formoterol
Concentrations available for budesonide + formoterol
- 160mcg/4.5mcg
- 160mcg/4.5mcg/dose
- 320mcg/9mcg
- 320mcg/9mcg/dose
- 80mcg/2.25mcg/dose
- 80mcg/4.5mcg/dose